GLOBAL NEWBORN SCREENING MARKET 2019-2027

MARKET OUTLOOK
According to a study by Triton, the global market for newborn screening is anticipated to grow at a CAGR of 13.76% over the forecast duration of 2019-2027.
Newborn screening procedures/tests involve a set of blood tests and other tests to seek evidence of certain genetic and endocrine diseases. The screening is performed to identify several medical conditions such as galactosemia, sickle cell disease, congenital hypothyroidism, phenylketonuria, among others. These tests have the potential to detect the risk of diseases prior to the appearance of clinical symptoms at an early stage, the early treatment of which can prevent premature death, spasticity, mental retardation and serious illnesses.
Due to the rise in the pervasiveness of congenital diseases, a large number of newborns are being affected by such conditions, which is a major driver for the newborn screening market. Moreover, government backing for newborn child health and the rising awareness for congenital heart disease in newborns are further pushing the growth of the market significantly. The increase in the global fertility rate has proven to be beneficial for the growth of the market. Furthermore, newborn screening helps in the early identification and management of affected newborns. Technological advancements in newborn screening and increase in the number of pregnant women with advanced maternal age can be used as opportunities for the growth of the market. On the flip side, the absence of proper healthcare infrastructure for newborn babies in developing countries and the socio-economic hurdles in the implementation of newborn child screening act as major restraints for the growth of the market. Furthermore, the dearth of skilled professionals in the healthcare industry and maintenance issues of hospital equipment severely limit the growth of the newborn screening market.
REGIONAL OUTLOOK
The global newborn screening market spans across five major regions, namely, Latin America, Europe, North America, Asia-Pacific and the Middle East and Africa.
The Asia-Pacific newborn screening market is the leading market globally, with the highest CAGR. In addition, North America’s supportive policies further supplement the growth of the newborn screening market in the US and Canada. For instance, the United States Government has mandated the newborn hearing screening among all the territories and 50 states of the United States since 1996, as per the Journal of Early Hearing Detection and Intervention (JEHDI), 2016 research. Further, in 2011, the US Department of Health and Human Services (HHS) added critical congenital heart defects (CCHD) in the Recommended Uniform Screening Panel for all the newborns born in the US. Further, high healthcare and R&D expenditure in the US and Canada also act as drivers for the growth of the newborn screening market in North America.
COMPETITIVE OUTLOOK
The dominant companies in the market are Trivitron Healthcare, ZenTech S.A., Masimo Corporation, PerkinElmer, Inc., Agilent Technologies, Inc., SCIEX, Bio-Rad Laboratories, Inc., BioTek Instruments, Inc., Waters Corporation, Thermo Fisher Scientific, Inc., Cardinal Health, Inc., NeoGen Labs Pvt. Ltd., Medtronic Plc, Natus Medical, Incorporated and GE Healthcare Limited.
BioTek Instruments, Inc., is a medical device company that develops, manufactures and distributes microplate instrumentation and software. The company’s products include detection, liquid handling, robotics, software and robotics and accessories. It provides accessories such as BioStack integration kits, bottles and tubing, cables, cassettes, dispense or waste systems, filter accessories, filter cubes, filters, labware holders, lamps, manifolds, mirrors, miscellaneous, and test plates & reagents. It serves the pharmaceutical and healthcare industries. In October 2018, BioTek released a Peltier Cooling Module for the Cytation? Cell Imaging Multi-Mode Readers.

TABLE OF CONTENT
1. GLOBAL NEWBORN SCREENING MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.2.1. SUPPORTIVE GOVERNMENT POLICIES IN US AND CANADA
2.2.2. DEMAND FOR NEWBORN SCREENING INSTRUMENTS IS RISING STEADILY
2.2.3. GROWTH IN DRY BLOOD SPOT TEST
2.2.4. TECHNIQUES USED IN NEWBORN SCREENING TESTS
2.3. EVOLUTION & TRANSITION OF NEWBORN SCREENING
2.4. PORTER’S FIVE FORCE ANALYSIS
2.4.1. THREAT OF NEW ENTRANTS
2.4.2. THREAT OF SUBSTITUTE
2.4.3. BARGAINING POWER OF SUPPLIERS
2.4.4. BARGAINING POWER OF BUYERS
2.4.5. THREAT OF COMPETITIVE RIVALRY
2.5. KEY IMPACT ANALYSIS
2.5.1. RELIABILITY
2.5.2. COST
2.5.3. AVAILABILITY
2.5.4. TECHNOLOGICAL ADVANCEMENT
2.6. MARKET ATTRACTIVENESS INDEX
2.7. VENDOR SCORECARD
2.8. INDUSTRY COMPONENTS
2.8.1. RAW MATERIAL SUPPLIERS
2.8.2. MANUFACTURERS
2.8.3. DISTRIBUTORS
2.8.4. END-USERS
2.9. REGULATORY FRAMEWORK
2.10. INDUSTRY PLAYER POSITIONING
2.11. KEY MARKET STRATEGIES
2.11.1. PRODUCT LAUNCH
2.12. MARKET DRIVERS
2.12.1. INCREASE IN OCCURRENCES OF NEWBORN DISEASES
2.12.2. GROWING NUMBER OF INFANTS WITH BIRTH DEFECT
2.12.3. BACKING OF GOVERNMENT TOWARDS NEWBORN CHILD HEALTH
2.12.4. RISING AWARENESS FOR PEDIATRIC CONGENITAL HEART DISEASE
2.13. MARKET RESTRAINTS
2.13.1. ABSENCE OF PROPER HEALTHCARE INFRASTRUCTURE FOR NEWBORN BABIES IN DEVELOPING COUNTRIES
2.13.2. SOCIO-ECONOMIC HURDLES IN THE IMPLEMENTATION OF NEWBORN CHILD SCREENING
2.14. MARKET OPPORTUNITIES
2.14.1. INCREASING FERTILITY RATES ACROSS THE GLOBE IS CREATING DYNAMIC GROWTH
2.14.2. NEWBORN SCREENING HELPS IN EARLY IDENTIFICATION AND MANAGEMENT OF AFFECTED NEWBORNS
2.14.3. TECHNOLOGICAL ADVANCEMENTS IN NEWBORN SCREENING
2.14.4. INCREASE IN NUMBER OF PREGNANT WOMEN WITH ADVANCED MATERNAL AGE
2.15. MARKET CHALLENGES
2.15.1. DEARTH OF SKILLED PROFESSIONAL IN HEALTHCARE INDUSTRY
2.15.2. MAINTENANCE OF EQUIPMENT IN HOSPITAL
3. NEWBORN SCREENING MARKET OUTLOOK - BY PRODUCT
3.1. NEWBORN SCREENING INSTRUMENTS
3.2. NEWBORN SCREENING REAGENTS & ASSAY KITS
4. NEWBORN SCREENING MARKET OUTLOOK - BY TEST TYPE
4.1. HEARING SCREEN TEST
4.2. CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST
4.3. DRY BLOOD SPOT TEST
5. NEWBORN SCREENING MARKET OUTLOOK - BY TECHNOLOGY
5.1. TANDEM MASS SPECTROMETRY
5.2. PULSE OXIMETRY
5.3. ENZYME-BASED ASSAYS
5.4. DNA-BASED ASSAYS
5.5. ELECTROPHORESIS
5.6. OTHERS
6. NEWBORN SCREENING MARKET - REGIONAL OUTLOOK
6.1. NORTH AMERICA
6.1.1. MARKET BY PRODUCT
6.1.2. MARKET BY TEST TYPE
6.1.3. MARKET BY TECHNOLOGY
6.1.4. COUNTRY ANALYSIS
6.1.4.1. UNITED STATES
6.1.4.2. CANADA
6.2. EUROPE
6.2.1. MARKET BY PRODUCT
6.2.2. MARKET BY TEST TYPE
6.2.3. MARKET BY TECHNOLOGY
6.2.4. COUNTRY ANALYSIS
6.2.4.1. UNITED KINGDOM
6.2.4.2. GERMANY
6.2.4.3. FRANCE
6.2.4.4. SPAIN
6.2.4.5. ITALY
6.2.4.6. RUSSIA
6.2.4.7. REST OF EUROPE
6.3. ASIA-PACIFIC
6.3.1. MARKET BY PRODUCT
6.3.2. MARKET BY TEST TYPE
6.3.3. MARKET BY TECHNOLOGY
6.3.4. COUNTRY ANALYSIS
6.3.4.1. CHINA
6.3.4.2. JAPAN
6.3.4.3. INDIA
6.3.4.4. SOUTH KOREA
6.3.4.5. ASEAN COUNTRIES
6.3.4.6. AUSTRALIA & NEW ZEALAND
6.3.4.7. REST OF ASIA-PACIFIC
6.4. LATIN AMERICA
6.4.1. MARKET BY PRODUCT
6.4.2. MARKET BY TEST TYPE
6.4.3. MARKET BY TECHNOLOGY
6.4.4. COUNTRY ANALYSIS
6.4.4.1. BRAZIL
6.4.4.2. MEXICO
6.4.4.3. REST OF LATIN AMERICA
6.5. MIDDLE EAST AND AFRICA
6.5.1. MARKET BY PRODUCT
6.5.2. MARKET BY TEST TYPE
6.5.3. MARKET BY TECHNOLOGY
6.5.4. COUNTRY ANALYSIS
6.5.4.1. UNITED ARAB EMIRATES
6.5.4.2. TURKEY
6.5.4.3. SAUDI ARABIA
6.5.4.4. SOUTH AFRICA
6.5.4.5. REST OF MIDDLE EAST & AFRICA
7. COMPETITIVE LANDSCAPE
7.1. SCIEX
7.2. BIOTEK INSTRUMENTS, INC.
7.3. BIO-RAD LABORATORIES, INC.
7.4. CARDINAL HEALTH, INC.
7.5. GE HEALTHCARE, LIMITED
7.6. AGILENT TECHNOLOGIES, INC.
7.7. MASIMO CORPORATION
7.8. NATUS MEDICAL, INCORPORATED
7.9. MEDTRONIC PLC
7.10. THERMO FISHER SCIENTIFIC, INC.
7.11. NEOGEN LABS PVT. LTD.
7.12. PERKINELMER, INC.
7.13. ZENTECH S.A.
7.14. WATERS CORPORATION
7.15. TRIVITRON HEALTHCARE
8. METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY


LIST OF TABLES
TABLE 1: GLOBAL NEWBORN SCREENING MARKET, BY GEOGRAPHY, 2019-2027 (IN $ MILLION)
TABLE 2: MARKET ATTRACTIVENESS INDEX
TABLE 3: VENDOR SCORECARD
TABLE 4: REGULATORY FRAMEWORK
TABLE 5: LIST OF PRODUCT LAUNCHES
TABLE 6: GLOBAL INCIDENCE OF CHROMOSOMAL ABNORMALITIES IN NEWBORNS
TABLE 7: LEADING CAUSE OF INFANT DEATHS IN THE UNITED STATES
TABLE 8: INFANT MORTALITY RATE IN DEVELOPING COUNTRIES (TOTAL DEATHS/ 1000 LIVE BIRTHS)
TABLE 9: GLOBAL NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027 (IN $ MILLION)
TABLE 10: GLOBAL NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027 (IN $ MILLION)
TABLE 11: GLOBAL NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027 (IN $ MILLION)
TABLE 12: GLOBAL NEWBORN SCREENING MARKET, BY GEOGRAPHY, 2019-2027 (IN $ MILLION)
TABLE 13: NORTH AMERICA NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
TABLE 14: NORTH AMERICA NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027 (IN $ MILLION)
TABLE 15: NORTH AMERICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027 (IN $ MILLION)
TABLE 16: NORTH AMERICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027 (IN $ MILLION)
TABLE 17: EUROPE NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
TABLE 18: EUROPE NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027 (IN $ MILLION)
TABLE 19: EUROPE NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027 (IN $ MILLION)
TABLE 20: EUROPE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027 (IN $ MILLION)
TABLE 21: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
TABLE 22: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027 (IN $ MILLION)
TABLE 23: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027 (IN $ MILLION)
TABLE 24: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027 (IN $ MILLION)
TABLE 25: LATIN AMERICA NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
TABLE 26: LATIN AMERICA NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027 (IN $ MILLION)
TABLE 27: LATIN AMERICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027 (IN $ MILLION)
TABLE 28: LATIN AMERICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027 (IN $ MILLION)
TABLE 29: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
TABLE 30: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027 (IN $ MILLION)
TABLE 31: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027 (IN $ MILLION)
TABLE 32: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027 (IN $ MILLION)


LIST OF FIGURES
FIGURE 1: PORTER’S FIVE FORCE ANALYSIS
FIGURE 2: KEY BUYING IMPACT ANALYSIS
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: INDUSTRY PLAYER POSITIONING IN 2018 (IN %)
FIGURE 5: CAUSES OF DEATH AMONG NEWBORNS WORLDWIDE (0-27 DAYS)
FIGURE 6: FERTILITY RATE (AVERAGE BIRTHS PER WOMAN IN %) IN 2017
FIGURE 7: GLOBAL NEWBORN SCREENING MARKET, BY NEWBORN SCREENING INSTRUMENTS, 2019-2027 (IN $ MILLION)
FIGURE 8: GLOBAL NEWBORN SCREENING MARKET, BY NEWBORN SCREENING REAGENTS & ASSAY KITS, 2019-2027 (IN $ MILLION)
FIGURE 9: GLOBAL NEWBORN SCREENING MARKET, BY HEARING SCREEN TEST, 2019-2027 (IN $ MILLION)
FIGURE 10: GLOBAL NEWBORN SCREENING MARKET, BY CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST, 2019-2027 (IN $ MILLION)
FIGURE 11: GLOBAL NEWBORN SCREENING MARKET, BY DRY BLOOD SPOT TEST, 2019-2027 (IN $ MILLION)
FIGURE 12: GLOBAL NEWBORN SCREENING MARKET, BY TANDEM MASS SPECTROMETRY, 2019-2027 (IN $ MILLION)
FIGURE 13: GLOBAL NEWBORN SCREENING MARKET, BY PULSE OXIMETRY, 2019-2027 (IN $ MILLION)
FIGURE 14: GLOBAL NEWBORN SCREENING MARKET, BY ENZYME-BASED ASSAY, 2019-2027 (IN $ MILLION)
FIGURE 15: GLOBAL NEWBORN SCREENING MARKET, BY DNA-BASED ASSAYS, 2019-2027 (IN $ MILLION)
FIGURE 16: GLOBAL NEWBORN SCREENING MARKET, BY ELECTROPHORESIS, 2019-2027 (IN $ MILLION)
FIGURE 17: GLOBAL NEWBORN SCREENING MARKET, BY OTHERS, 2019-2027 (IN $ MILLION)
FIGURE 18: GLOBAL NEWBORN SCREENING MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
FIGURE 19: UNITED STATES NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 20: CANADA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 21: UNITED KINGDOM NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 22: GERMANY NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 23: FRANCE NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 24: SPAIN NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 25: ITALY NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 26: RUSSIA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 27: REST OF EUROPE NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 28: CHINA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 29: JAPAN NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 30: INDIA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 31: SOUTH KOREA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 32: ASEAN COUNTRIES NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 33: AUSTRALIA & NEW ZEALAND NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 34: REST OF ASIA-PACIFIC NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 35: BRAZIL NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 36: MEXICO NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 37: REST OF LATIN AMERICA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 38: UNITED ARAB EMIRATES NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 39: TURKEY NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 40: SAUDI ARABIA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 41: SOUTH AFRICA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 42: REST OF MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)